Substituted porphyrins

Details Substituted porphyrins Substituted porphyrins

2007-03-13

2007-03-13

Pryor, Alton (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S365000, C514S383000, C514S397000, C514S406000, C514S410000

Reexamination Certificate

active

10349171

ABSTRACT:
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.

REFERENCES:
patent: 4614723 (1986-09-01), Schmidt
patent: 4657902 (1987-04-01), Kappas et al.
patent: 4746735 (1988-05-01), Kruper, Jr. et al.
patent: 4758422 (1988-07-01), Quay
patent: 4837221 (1989-06-01), Bonnett
patent: 4851403 (1989-07-01), Picker et al.
patent: 4892941 (1990-01-01), Dolphin et al.
patent: 4895719 (1990-01-01), Radhakrishnam
patent: 4963367 (1990-10-01), Ecanow
patent: 5051337 (1991-09-01), Sakoda et al.
patent: 5130245 (1992-07-01), Marklund et al.
patent: 5162519 (1992-11-01), Bonnett
patent: 5169630 (1992-12-01), Okaya et al.
patent: 5171680 (1992-12-01), Mullenbach et al.
patent: 5192757 (1993-03-01), Johnson et al.
patent: 5202317 (1993-04-01), Bruice
patent: 5217966 (1993-06-01), Bruice
patent: 5223538 (1993-06-01), Fridovich
patent: 5227405 (1993-07-01), Fridovich
patent: 5236914 (1993-08-01), Meunier
patent: 5236915 (1993-08-01), Fiel
patent: 5248603 (1993-09-01), Marklund et al.
patent: 5262532 (1993-11-01), Tweedle et al.
patent: 5281616 (1994-01-01), Dixon et al.
patent: 5284647 (1994-02-01), Niedballa
patent: 5366729 (1994-11-01), Marklund et al.
patent: 5472691 (1995-12-01), Marklund et al.
patent: 5599924 (1997-02-01), Therien et al.
patent: 5674467 (1997-10-01), Maier et al.
patent: 5747026 (1998-05-01), Crapo
patent: 5767272 (1998-06-01), Wijesekera et al.
patent: 5834509 (1998-11-01), Malfroy-Camine et al.
patent: 5948771 (1999-09-01), Danziger
patent: 5994339 (1999-11-01), Crapo et al.
patent: 5994410 (1999-11-01), Chiang et al.
patent: 6046188 (2000-04-01), Malfroy-Camine et al.
patent: 6084093 (2000-07-01), Riley et al.
patent: 6087493 (2000-07-01), Wheelhouse et al.
patent: 6103714 (2000-08-01), Fridovich et al.
patent: 6127356 (2000-10-01), Crapo et al.
patent: 0 127 797 (1984-12-01), None
patent: 0 186 962 (1986-07-01), None
patent: 0 282 899 (1988-09-01), None
patent: 0 336 879 (1989-10-01), None
patent: 0 337 601 (1989-10-01), None
patent: 0 345 171 (1989-12-01), None
patent: 0 414 915 (1991-03-01), None
patent: 0 462 836 (1991-12-01), None
patent: 0 524 161 (1993-01-01), None
patent: 0 532 327 (1993-03-01), None
patent: 2 676 738 (1992-11-01), None
patent: WO 91/04315 (1991-04-01), None
patent: WO 92/07935 (1992-05-01), None
patent: WO 93/02090 (1993-02-01), None
patent: WO 94/04614 (1994-03-01), None
patent: WO 94/05285 (1994-03-01), None
patent: WO 95/10185 (1995-04-01), None
patent: WO 95/31197 (1995-11-01), None
patent: WO 96/09038 (1996-03-01), None
patent: WO 96/09053 (1996-03-01), None
patent: WO 96/40223 (1996-12-01), None
patent: WO 98/33503 (1998-06-01), None
patent: WO 99/23097 (1999-05-01), None
patent: WO 99/55388 (1999-11-01), None
patent: WO 00/43395 (2000-07-01), None
patent: WO 01/26655 (2001-04-01), None
patent: WO 01/96345 (2001-12-01), None
O'hara et al, “Potentiation of radiation-induced cell kill by synthetic metalloporphyrins”, Int. J. Radiat. Oncol. Biol. Phys. 16(4):1049-1052 (1989).
Lee et al, “Rapid decomposition of peroxynitrite by manganese porphyrin-antioxidant redox couples”, Bioorganic & Medical Chemistry Letters 7(22):2913-2918 (1997).
Madakyan et al, “New watersoluble metal complexes ofmeso-tetrakis[3-N-(2′-hydroxy ethyl)pyridyl]porphyrins and their pharmacological activity”, Arm. Khim. Zh. 42(11):724-728—Chemical Abstracts 113:653—Abstract No. 114907h.
Wheelhouse et al, “Cationic Porphyrins as Telomerase Inhibitors; the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA”, J. Am. Chem. Soc. 120(13):3261-3262 (1998).
Zahedi, “Semiempirical molecular orbital calculations of biliverdin: study of dynamics and energetics of the self-association of a two-electron oxidation product”, Theochem. 531:79-88 (2000).
Lord, “Redox characteristics of nickel and palladium complexes of the open-chain tetrapyrrole octaethylbilindione: a biliverdin model”, Inorg. Chem. 39(6):1128-1134 (2000).
Balch, “Isolation and characterization of an iron biliverdin-type complex that is formed along with verdohemochrome during the coupled oxidation of iron (II) octaethylporphyrin”, Am. Chem. Soc. 115(20):9056-9061 (1993).
Koerner, “Carbon monoxide production during the oxygenation of cobalt complexes of linear etrapyrroles”, Inorg. Chem. 37(5):982-988 (1998).
Balch, “Solid-state self-association of the two-electron oxidation product of a biliverdin analogue”, J. Chem. Soc. Chem. Commun. 6:643-644 (1995).
Balch, “Geometric and electronic structure and dioxygen sensitivity of the copper complex of octaethylbilindione, a biliverdin analog”, J. Am. Chem. Soc. 115(25):12206-12207 (1993).
Falk, “Constributions to the chemistry of pyrrolic pigments”, Tetrahedron 37(4):761-767 (1981).
Burke, “Photochemical and thermal transformations of phytochrome”, Chem. Physiol. Bile Pigm., Int. Symp., pp. 509-517 (1975).
Madakyan et al, “Some metal complexes of meso-tetrakis (3-N-substituted pyridyl) porphyrins and their bioactivity”, Arm. Khim. Zh. 42(10);642-646 (1989).
Crapo et al, 721195, Document No. 123:218443 (1995).
Sheldon, Chapter 1 in Metalloporphyrins in Catalytic Oxidations, Marcel Dekker, Inc. (1994).
Butje et al, “Electronic Spectra, Resonance Raman Spectra and Solution Properties of Water-soluble (Cu(II), Ni(II) and Co(III) Porphrins”, Inorg. Chim. Acta 167:97-108 (1990).
Davila et al, “Sterically-Hindered Zinc Prophyrins for Solar-Energy Conversion”, J. Chem. Soc., Chem. Commun., pp. 525-527 (1987).
Kaufmann et al, “Separation of the Rotational Isomers of Tetrakis(N-methyl-2-pyridiniumyl)porphyrin and Crystal Sturcture of ∀,∀,∀,∃-(Tetrakis(N-methyl-2-pyridiniumyl)porphyrin)copper Hexacyanoferrate”, Inorg. Chem. 34:5073-5079 (1995).
Sari et al, “Interaction of Cationic Porphyrins with DNA: Importance of the No. and Position of the Charges and Minimum Structural Requirements for Intercalation”, Biochemistry 29:4205-4215 (1990).
Vodzinskii et al, “Porphyrines and Their Derivatives. XX. Synthesis and Properties of 2-Nitro-5,10,15,20-tetraheterylporphyrins”, Russian Journal of Organic Chemistry 34(6):882-885 (1998).
Hambright et al, “Manganese(III) porphyrin isomers: polarography and stannous ion reduction kinetics”, Porphyrin Chem. Adv., editor: Longo, [Pap. Porphyrin Symp.], pp. 284-292, Meeting Date 1977.
Batinic-Haberle et al, “A Potent Superoxide Dismutase Mimic” Manganese[B]-Octabromo-meso-tetrakis-(N-methylpyridinium-4-yl)Porphyrin, Archives of Biochemistry and Biophysics 343(2):225-233 (1997).
Crapo and Tierney, “Superoxide dismutase and pulmonary oxygen toxicity”, Am. J. Physiol. 226:1401-1407 (1974).
Callot and Schaeffer, “Ring contraction of homoporphyrins to porphyrins,meso-Reactivity of 5,10,15-Triphenylporphin and Porphin”, J. Chem. Research (S):51 (1978).
Inoue et al, “Expression of a Hybrid Cu/Zn-type Superoxide . . . ,” J. Bio. Chem., vol. 266, No. 25, pp. 16409-16414 (1991).
Day et al, “Manganic Porphyrins Possess Catalase Activity . . . ,” Arch. Biochem. Biophys., vol. 347, No. 2, pp. 256-262 (1997).
Tsan, M-F., “Superoxide Dismutase and Pulmonary Oxygen Toxicity,” XP-002074505, pp. 286-290.
Foran et al, “Effect of Electrolyte Concentration on Axial Anion Ligation in Manganese(III)meso-Tetraphenylporphyrin Chlorides”, Inorg. Chem. 31:1463-1470 (1992).
Milgrom, Facile Aerial Oxidation of a Porphyrin. Part 3. Some Metal Complexes ofmeso-Tetrakis-(3,5-di-t-butyl-4-hydroxphenyl)porphyrin, J. Chem. Soc. Perkin Trans. 11:71-79 (1988).
Bockhorst and Hoehn-Beriage,

Affiliated with

Also associated with

Rating

Substituted porphyrins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted porphyrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted porphyrins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3764529